E10.3491 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye

Name of the Condition

• Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye

Summary

Type 1 diabetes mellitus is a chronic autoimmune condition characterized by insufficient insulin production. When associated with severe nonproliferative diabetic retinopathy without macular edema, it indicates advanced retinal damage due to prolonged hyperglycemia. This stage involves widespread microaneurysms, intraretinal hemorrhages, venous beading, and intraretinal microvascular abnormalities without neovascularization or macular fluid accumulation. The right eye is specifically affected, requiring targeted monitoring to prevent progression to proliferative disease or vision loss.

Causes

Type 1 diabetes arises from an autoimmune response that destroys insulin-producing beta cells in the pancreas. Severe nonproliferative diabetic retinopathy without macular edema develops as a result of sustained high blood glucose levels, which damage retinal blood vessels over time. The exact mechanisms involve oxidative stress, inflammation, and vascular changes specific to ocular structures, leading to progressive retinal ischemia and structural damage without macular involvement in the right eye.

Risk Factors

• Poor glycemic control
• Duration of diabetes (longer exposure increases risk)
• Hypertension
• Dyslipidemia
• Smoking
• Genetic predisposition to diabetic eye disease

Symptoms

• Blurred or distorted vision in the right eye
• Floaters or spots in the visual field of the right eye
• Difficulty seeing in low light (right eye)
• Reduced visual acuity in the right eye

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated retinal imaging (e.g., fundus photography or optical coherence tomography) to assess retinal changes. Visual acuity testing and fluorescein angiography may be used to evaluate microvascular abnormalities and rule out macular edema. Laboratory tests to confirm diabetes control (e.g., HbA1c) and systemic risk factors (e.g., blood pressure, lipid levels) are also performed.

Treatment Options

Treatment focuses on optimizing glycemic control through insulin therapy and lifestyle modifications. Ocular management may include regular monitoring, blood pressure and lipid control, and anti-VEGF therapy if macular edema develops. Laser photocoagulation is not typically indicated at this stage but may be considered for proliferative changes. Referral to a retina specialist is recommended for advanced cases.

Prognosis and Follow-Up

Prognosis depends on glycemic control and timely intervention. Without proper management, severe nonproliferative diabetic retinopathy may progress to proliferative disease or vision loss. Regular follow-up (every 3–6 months) with an ophthalmologist is essential to monitor retinal changes and adjust treatment as needed.

Complications

• Progression to proliferative diabetic retinopathy
• Vision loss in the right eye
• Macular edema (if uncontrolled)
• Increased risk of cataracts or glaucoma

Lifestyle & Prevention

• Maintain strict glycemic control (target HbA1c <7%)
• Monitor blood pressure and lipid levels regularly
• Avoid smoking and limit alcohol intake
• Engage in regular physical activity
• Follow a balanced diet rich in fruits, vegetables, and whole grains

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, increased floaters, or eye pain in the right eye. Regular eye exams are critical for early detection of retinal changes.

Tips for Medical Coders

Document the specific eye (right eye) and absence of macular edema to support the code E10.3491. Include clinical details such as retinal findings (e.g., microaneurysms, hemorrhages) and diabetes management history. Ensure documentation aligns with the severity of nonproliferative diabetic retinopathy and confirms no macular edema.